Phibro Animal Health Corp. 8-K Summary
Business Context and Reporting Period
Phibro Animal Health Corporation (PAHC) filed this Form 8-K on August 27, 2025. The filing serves to announce the company's operating results for the fourth quarter and the full fiscal year ended June 30, 2025. Additionally, the filing includes financial guidance for the upcoming fiscal year ending June 30, 2026.
Key Financial Metrics
The provided text is a cover page and index for the 8-K filing. It references a press release (Exhibit 99.1) containing the specific financial data but does not list the actual figures within this document.
- Revenue, Profit, Cash Flow, Margins: The filing text does not provide a clear value for these metrics.
- Debt and Liquidity: The filing text does not provide a clear value for these metrics.
Material Changes
The filing text does not provide a clear value regarding specific material changes versus the prior comparable period. Investors must refer to the attached press release (Exhibit 99.1) for comparative analysis.
Guidance, Outlook, and Risks
Management has issued financial guidance for the fiscal year ending June 30, 2026, as detailed in the press release furnished as Exhibit 99.1. The filing explicitly states that the information contained in the report and exhibits is "furnished" and not "filed" for purposes of Section 18 of the Exchange Act, nor is it incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated August 27, 2025) for specific Q4 and full-year 2025 financial results.
- Verify the specific numerical targets provided in the guidance for fiscal year 2026.
- Confirm the details of any unusual items or contingencies discussed in the full press release text.
- Note that the 8-K itself does not contain the financial tables; it only references the external press release.